About Alpha-(1,3)-fucosyltransferase 4
Alpha-(1,3)-fucosyltransferase 4 (FUT4) is a protein
from Homo sapiens identified by UniProt accession
P22083, 530 residues long.
MolForge cross-references it against 0 known binders and
521 disease associations.
Target properties
| Protein name | Alpha-(1,3)-fucosyltransferase 4 |
| UniProt accession | P22083 |
| Gene | FUT4 |
| Organism | Homo sapiens |
| Length | 530 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (521)
Diseases linked to this target (Open Targets).
- neoplasm · score 0.11
- endometriosis · score 0.09
- cancer · score 0.09
- blood protein measurement · score 0.09
- acute myeloid leukemia · score 0.08
- melanoma · score 0.08
- papillary thyroid carcinoma · score 0.08
- lung adenocarcinoma · score 0.08
- nonpapillary renal cell carcinoma · score 0.07
- non-small cell lung carcinoma · score 0.06
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-P22083-F1 | alphafold | PREDICTED | 73.08 | — |
Amino-acid sequence (530 residues)
MRRLWGAARK PSGAGWEKEW AEAPQEAPGA WSGRLGPGRS GRKGRAVPGW ASWPAHLALA ARPARHLGGA GQGPRPLHSG TAPFHSRASG ERQRRLEPQL QHESRCRSST PADAWRAEAA LPVRAMGAPW GSPTAAAGGR RGWRRGRGLP WTVCVLAAAG LTCTALITYA CWGQLPPLPW ASPTPSRPVG VLLWWEPFGG RDSAPRPPPD CRLRFNISGC RLLTDRASYG EAQAVLFHHR DLVKGPPDWP PPWGIQAHTA EEVDLRVLDY EEAAAAAEAL ATSSPRPPGQ RWVWMNFESP SHSPGLRSLA SNLFNWTLSY RADSDVFVPY GYLYPRSHPG DPPSGLAPPL SRKQGLVAWV VSHWDERQAR VRYYHQLSQH VTVDVFGRGG PGQPVPEIGL LHTVARYKFY LAFENSQHLD YITEKLWRNA LLAGAVPVVL GPDRANYERF VPRGAFIHVD DFPSASSLAS YLLFLDRNPA VYRRYFHWRR SYAVHITSFW DEPWCRVCQA VQRAGDRPKS IRNLASWFER
Explore Alpha-(1,3)-fucosyltransferase 4 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets